The city of Los Angeles, California, currently has 13 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
The goal of this clinical trial is to learn about INS018_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
07/25/2024
Locations: Keck School of Medicine of USC, Los Angeles, California
Conditions: Idiopathic Pulmonary Fibrosis (IPF)